申请人:SMITHKLINE BEECHAM INTERCREDIT B.V.
公开号:EP0393926A1
公开(公告)日:1990-10-24
Compounds of structure (I)
in which R1 is C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkylC1-6alkyl, phenyl(CH2)m the phenyl group being optionally substituted by 1-3 radicals selected from C1-6alkyl, C1-6alkoxy, amino C1-6alkylthio, halogen, cyano, hydroxy, carbamoyl, carboxy, C1-6alkanoyl and trifluoromethyl or Het(CH2)m in which Het is a 5 or 6 membered carbocyclic ring containing one or more heteroatoms and m is 0 to 6; R2 is C1-6alkyl, phenyl, C1-6alkoxy, C1-6alkylthio, hydroxy, Cl-6alkanoyl, amino, C1-6alkylamino, di-C1-6alkylamino, halogen, trifluoromethyl or cyano; R3 is hydrogen or C1-4alkyl; n is 0, 1 or 2, and the dotted line indicates the optional presence of a double bond; processes for their preparation, pharmaceutical compositions containing them and their use in therapy as inhibitors of gastric acid secretion.
结构(I)的化合物
其中 R1 是 C1-6 烷基、C3-6 环烷基、C3-6 环烷基-C1-6 烷基、苯基(CH2)m(苯基可任选被 1-3 个选自 C1-6 烷基、C1-6烷氧基、氨基、C1-6烷硫基、卤素、氰基、羟基、氨基甲酰基、羧基、C1-6烷酰基和三氟甲基的基团取代)或 Het(CH2)m(其中 Het 是含有一个或多个杂原子的 5 或 6 成员碳环,m 为 0 至 6);R2是C1-6烷基、苯基、C1-6烷氧基、C1-6烷硫基、羟基、Cl-6烷酰基、氨基、C1-6烷基氨基、二-C1-6烷基氨基、卤素、三氟甲基或氰基;R3是氢或C1-4烷基;n是0、1或2,虚线表示任选存在的双键;它们的制备工艺、含有它们的药物组合物以及它们作为胃酸分泌抑制剂的治疗用途。